Monday, June 17, 2013 5:40:55 PM
by Jonas Korlach, Chief Scientific Officer
Finished genomes were the focus of last month's Sequencing, Finishing, Analysis in the Future (SFAF) meeting in Santa Fe, New Mexico. In addition to several presentations, including a talk by Adam Phillippy from the National Biodefense Analysis and Countermeasures Center that demonstrated the ability to generate high-quality, finished microbial genomes using just long-read PacBio data, several papers have appeared recently describing the same principle: the HGAP/Quiver Nature Methods paper, the FDA’s Salmonella Javiana outbreak genome publication, a blog entry by the University of Maryland using HGAP, and a preprint by Adam Phillippy and colleagues describing a similar genome assembly strategy and results.
These presentations and papers highlight the fact that SMRT® Sequencing, in conjunction with the appropriate bioinformatics tools, achieves highly accurate genomes, exceeding 99.999% accuracy, despite a higher single-pass error rate. This is possible because final genome assemblies build sequence through consensus(1); as the errors in SMRT Sequencing are random, very high consensus accuracy can be achieved.
Long reads and consensus are also at the heart of the genome assemblers appropriate for our type of sequencing reads. These overlap-based assemblers such as Celera® Assembler or MIRA — originally developed during the era of Sanger sequencing — are robust to errors. The long reads provide ample information about which reads belong together in pair-wise alignments, thereby connecting them properly for a correct genome assembly. In contrast, short-read technologies have largely relied on de Bruijn graph-based assemblers: short reads are fragmented further from which a K-mer graph is constructed and the assembly is derived.(2) As such, de Bruijn graph assemblers are very sensitive to single-read errors, which is why there has been a focus on single-pass sequence read accuracy in recent years.(3) Overlap and de Bruijn assemblers therefore differ fundamentally in their approach, highlighting the fact that the right bioinformatic tools need to be applied together with different types of sequencing data, and different parameters need to be evaluated for their performance.
We are excited about the application of these new assembly strategies to large numbers of microbial genomes (e.g., in the context of the 100K Foodborne Pathogen Genome Project) to close the large gap that currently exists between draft genomes and finished genomes in GenBank. Finished microbial genomes are the foundation for functional genomics studies, comparative genomics, forensics, microbial outbreak source identification, and phylogenetic analysis, and are thereby crucial for understanding microbes and advancing the field of microbiology.(4) Sequencing microbial genomes de novo, i.e. without the need for a pre-existing reference genome, is important to capture novel elements, such as plasmids or phages. These are sometimes referred to as the accessory genome(5), and can make the crucial difference between a commensal, harmless bacterium and a serious, perhaps drug-resistant pathogen.
References
1. S. Junemann, F. J. Sedlazeck, K. Prior et al., Nat Biotechnol 31 (4), 294 (2013).
2. J. R. Miller, S. Koren, and G. Sutton, Genomics 95 (6), 315 (2010).
3. N. J. Loman, C. Constantinidou, J. Z. Chan et al., Nat Rev Microbiol 10 (9), 599 (2012).
4. C. M. Fraser, J. A. Eisen, K. E. Nelson et al., J Bacteriol 184 (23), 6403 (2002).
5. D. Croll and B. A. McDonald, PLoS Pathog 8 (4), e1002608 (2012). http://blog.pacificbiosciences.com/2013/06/two-worlds-of-genome-assemblers.html
Recent PACB News
- PacBio and International Research Consortium CoLoRS Announce Release of First-Ever HiFi Long-Read Variant Database • PR Newswire (US) • 06/10/2024 01:05:00 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 05/30/2024 01:52:04 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/22/2024 09:25:43 PM
- Ambry Genetics and PacBio Announce Collaboration to Sequence Up to 7,000 Human Genomes Aimed at Providing Answers for Families Battling Rare Diseases • PR Newswire (US) • 05/15/2024 01:45:00 PM
- Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers • Edgar (US Regulatory) • 05/09/2024 08:33:12 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/09/2024 08:21:46 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2024 08:12:15 PM
- PacBio Announces First Quarter 2024 Financial Results • PR Newswire (US) • 05/09/2024 08:05:00 PM
- PacBio Announces Preliminary First Quarter 2024 Revenue and Updates 2024 Revenue Guidance • PR Newswire (US) • 04/16/2024 12:05:00 PM
- Estonia National Biobank Selects PacBio to Sequence 10,000 Whole Genomes • PR Newswire (US) • 03/27/2024 12:00:00 PM
- PacBio Grants Equity Incentive Award to New Employee • PR Newswire (US) • 03/22/2024 08:30:00 PM
- PacBio Announces PureTarget™ Repeat Expansion Panel, Expanding its Portfolio of End-to-End Clinical Research Solutions • PR Newswire (US) • 03/12/2024 01:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 10:36:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 10:30:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 10:26:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 10:22:45 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/04/2024 11:32:39 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/04/2024 11:22:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/26/2024 09:55:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/26/2024 09:36:09 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/26/2024 09:25:48 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/26/2024 09:19:42 PM
- PacBio to Present at Upcoming Investor Conferences • PR Newswire (US) • 02/26/2024 09:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/21/2024 11:25:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/21/2024 11:20:57 PM
FEATURED Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • Jun 14, 2024 2:07 AM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Snakes & Lattes Opens Pop-Up Location at The Wellington Market in Toronto: A New Destination for Fun and Games - Thanks 'The Well', PepsiCo, Indie Pale House & All Sponsors & Partners for Their Commitment & Assistance Throughout The Process • FUNN • Jun 13, 2024 8:18 AM
HealthLynked Introduces Innovative Online Medical Record Request Form Using DocuSign • HLYK • Jun 12, 2024 8:00 AM
Ubiquitech Software Corp (OTC:UBQU) Posts $624,585 Quarterly Revenue - Largest Quarter Since 2018 • UBQU • Jun 11, 2024 10:13 AM
Element79 Gold Corp Files for OTCQB Uplisting, Provides Financial Update • ELEM • Jun 11, 2024 9:25 AM